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Background: The Dutch government recently added universal Human Papilloma Virus (HPV) vaccination for
12-year-old girls to the existing national immunization program. The participation rate for the initial catch-up campaign
for girls aged 13 to 16 years in 2009 was lower (47%) than expected (70%). To inform future HPV information
campaigns, this paper examines the social and psychological determinants of the HPV vaccination intentions of girls
aged 13 to 16 years and their mothers who were targeted by the Dutch catch-up campaign of 2009.
Methods: A random sample of girls and their mothers was chosen from the Dutch vaccination register and received a
letter inviting them to participate (n = 5,998 mothers and daughters). In addition, a random sample was recruited via
an online panel by a marketing research company (n = 650 mothers; n = 350 daughters). Both groups were asked to
complete a web-based questionnaire with questions on social demographic characteristics, social-psychological factors
and HPV vaccination intention. Backward linear regression analyses were conducted to examine which
social-psychological factors were most dominantly associated with vaccination intention.
Results: Data from 952 mothers (14%) and 642 daughters (10%) were available for the intended analyses. The
contribution of social demographic variables to the explained variance of HPV vaccination intention was small but
significant for mothers (ΔR2 = .01; p = .007), but not significant for daughters (ΔR2 = .02; p = .17) after controlling for
HPV vaccination uptake and the sample. In addition, social-psychological determinants largely contributed to the
explained variance of HPV vaccination intention of mothers (ΔR2 = .35; p < .001) and daughters (ΔR2 = .34; p < .001).
Attitudes, beliefs, subjective norms and habit strength were significantly associated with participants’ HPV vaccination
intentions.
Conclusions: Because of the large contribution of social-psychological variables to the explained variance of HPV
vaccination intentions among the mothers and daughters, future communication strategies targeting HPV
vaccination uptake should address attitudes, beliefs, subjective norms and habit strength. There is a need for
longitudinal research to confirm the causality of the association between these determinants and HPV vaccination
behavior indicated by this study.
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Despite a long-standing efficient national cervical cancer
screening program for women aged 30 to 60 (uptake 66%)
[1], 600 new cases of cervical cancer are still diagnosed
every year in the Netherlands, and 200 of these patients
will eventually die from the disease [2]. The major cause
of cervical cancer is persistent infection by the Human
Papilloma Virus (HPV) [3], the most common sexually
transmitted infection among young women [2,3]. Of all
HPV types, types 16 and 18 are responsible for about 70%
of cervical cancer cases [4,5]. To prevent persistent
HPV infection, two vaccines have been licensed in Europe:
CervarixW GSK and GardasilW. The Dutch Health Council
estimated that the annual number of new cervical cancer
cases in the Netherlands could be reduced by 50% by
adding universal HPV vaccination of 12-year-old girls to
the cervical cancer screening program [2]. The Dutch
government decided to implement the CervarixW GSK
vaccine for this age group in the National Immunization
Program (NIP), starting in 2010. Each year, the new cohort
of 12-year-old girls will be invited to receive the HPV
vaccination. The full schedule for this non-mandatory,
free vaccine includes three injections (i.e., baseline, at one
month and at six months).
In 2009, a HPV vaccination catch-up campaign
was organized for girls born between 1993 and 1996
(at that time, 13 to 16 years of age). As with other
NIP campaigns, this campaign was coordinated by the
National Institute for Public Health and the Environment
(RIVM). The accompanying information campaign
consisted of an information pamphlet sent to the home
addresses of the girls invited, a website with information
about the HPV vaccination for girls and parents, and
references to a help line. The Community Health Services,
which is responsible for the local implementation of
the HPV vaccination, organized local mass vaccination
sites for girls.
The Dutch NIP, initially implemented in 1999, is one
of the most cost-effective public health programs with a
consistently high and stable vaccine coverage [6]. About
95% of infants and young children in the Netherlands
are vaccinated under the universal childhood vaccination
program [7]. The expected participation rate for the HPV
campaign was 70%, for several reasons (e.g., the novelty of
the vaccine, a new age group, the targeting only of girls
and a vaccine targeting sexual transmitted infection) [8].
However, the 2009 participation rate turned out to be
much lower, with 57%, 56% and 52% of the invited girls
completing one, two, and three vaccinations, respectively
[9]. The participation rate remained low in 2010 and 2011
(56% and 54%, respectively) [10,11].
In response to this rather low participation rate,
research into the social-psychological determinants of
the HPV vaccination decision was initiated to providedirection for the improvement of future HPV vaccine
communication to girls and parents used by public
health officials to improve vaccination uptake. Because
dropout after the first HPV injection (i.e., those who
received only one dose) was low in 2010 (5%), these
insights into the decision to receive the vaccination can
be used to improve the total vaccination uptake. This
paper reports on the outcomes of our research on the
social-psychological determinants of the HPV vaccination
intentions of girls and parents who were targeted by the
Dutch catch-up campaign in 2009.
Because the HPV vaccine has only recently been
introduced worldwide, most studies have focused on
determinants of future acceptance of the HPV vaccination
before implementation [12-15]. Reviews indicate that the
following factors were most likely to be associated with
future acceptance of the HPV vaccine: perceived effective-
ness of the vaccine, perceived risks of the vaccine, perceived
barriers (e.g., vaccine costs, concerns that the vaccine
would promote adolescent sexual behavior), physicians’
recommendations and the opinions of significant others
(i.e., subjective norms) [12-15]. Only a few studies have
examined determinants of HPV vaccination acceptance
after implementation of the vaccine [16-20]. Most of the
determinants found in studies conducted before imple-
mentation were confirmed empirically by the studies
following implementation of the HPV vaccine [16-20].
However, studies conducted after implementation found
additional factors: attitude, knowledge, perceived harm
and perceived behavioral control [16-20].
Even after implementation of the HPV vaccine, determi-
nants of intention to take the HPV vaccination among girls
and parents who do not have to make the decision in the
immediate future may differ from those who have actually
made the decision and were asked whether they would
make it again. Focusing on participants in the latter group
is important, because it may improve the explained
variance of HPV vaccination intention.
The present study is one of the first to examine
determinants of the HPV vaccination intentions among
participants who made a decision about the HPV vaccin-
ation. In addition, this study is one of the first to examine
the extent to which determinants contribute to the HPV
vaccination intention. The participants were Dutch girls
and their mothers who received an invitation for the first
catch-up campaign in 2009.
Given the young age of the girls involved, most studies
acknowledge that parents play a large role in their
daughters’ HPV vaccination decision [12,16-27]. Some of
these studies specifically focused on mothers [16,18,25].
The present study focuses on the HPV vaccination
intention of both mothers and girls in order to explore
the possible differential impact of the determinants on
their HPV vaccination decision making. The research
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determinants of the HPV vaccination intentions of girls
and their mothers who were targeted by the Dutch
catch-up campaign in 2009?
Methods
This cross-sectional study used a quantitative retrospective
approach by means of a web-based questionnaire offered
to girls born in 1995 and 1996 (at that time, aged 13
and 14 years) who were invited for the catch-up HPV
vaccination campaign in 2009 and their mothers. We
recruited study participants among this youngest cohort
only, because they best resembled the girls who will be tar-
geted by future campaigns. This research conformed to the
Helsinki Declaration and to local legislation. The study was
exempt from ethical review according to the Independent
Review Board Amsterdam, a medical ethics committee
acknowledged by the Central Committee on Research
Involving Human Subjects (CCMO).
The girls and their mothers received information
about the study in the invitation letter. Those who chose
to participate gave their informed consent by filling out
the questionnaire. In the invitation letter and at the start
of the questionnaire, participants were assured of their
privacy, the confidentiality and security of responses,
and informed that they could withdraw their participation
at any time. Their responses were anonymized; the
researchers were unable to verify participants’ names,
addresses and e-mail addresses. Participants accessed the
online questionnaire by using a log-in code, a unique
number. This number was only used by a third party
contact person from Praeventis for the Praeventis sample
and an online panel bureau for the online panel sample to
send reminders to those who did not respond to the first
invitation; see “Participants” section for more information
about the samples. Participants who completed the ques-
tionnaire were not able to participate for a second time.
Participants
A flow diagram of the recruitment and response of parti-
cipants is presented in Figure 1. The girls and mothers
were invited to participate in the study from November
2009 until January 2010. At that time, those girls who
agreed to take the HPV vaccination could have received
three injections.
Praeventis
Participants were invited via Praeventis, the Dutch
vaccination register hosted by RIVM. Mothers and
daughters that were invited came from the same family
unit. A computer program was used to draw a random
sample of 6,000 addresses of girls born in 1995 or 1996
that was stratified on known geographical differences in
vaccine uptake and ethnicity. Since the addresses of twoparticipants were unknown, the study invitation was sent
to 5,998 addresses. The invitation consisted of a single
letter addressing mothers of girls born in 1995 or 1996
and the girls themselves. The invitation included a brief
description of the study purpose, information about
anonymity of participation, a log-in number and an
explanation of the log-in procedure.
The online questionnaire for the Praeventis sample
was hosted on a private part of the TNO website, which
was only accessible through use of the log-in number.
Computer assisted self-interviewing was used for the
online questionnaire and participants were not rewarded
for filling out the questionnaire. The questionnaire was
open for response from November 30, 2009, until January
10, 2010. Mothers and daughters (n = 5,929; 99%) who had
not responded within three weeks after the first invitation
received a reminder. Of the 5,998 invited participants from
Praeventis, 564 mothers (9%) and 537 daughters (9%)
started the questionnaire, of which 445 mothers (79%) and
404 daughters (75%) fully completed the survey. A large
percentage of mothers and daughters who started (21%
and 25%, respectively) failed to complete the question-
naire. Male participants (n = 5) and those with an in-
valid age (n = 4) were excluded from the analyses. The
final response rate was 7% (N = 441) among the
mothers, and 7% (N = 399) among the daughters.
Online panel
Due to the Praeventis sample’s limited response to the
first invitation letter, we decided to recruit an extra
sample by using an online panel of a private marketing
research company. A computer program was used to
draw a random sample of 650 mothers of girls born in
1995 or 1996, and 350 of their daughters that was stratified
on age, education and geographical differences in vaccine
uptake. Among the online panel sample, 350 invited
mothers and daughters came from the same family unit.
They were sent an e-mail that offered the opportunity to
complete the questionnaire between December 18 and
December 24, 2009. The online panel was responsible for
collecting the data among the sample and TNO was owner
of the data. Computer assisted self-interviewing was used
for the online questionnaire, which was hosted on a private
part of the online panel website that was only accessible
through use of the log-in number. Participants from the
online panel sample were rewarded for completing the
questionnaire according to the standards of the online
panel company: they received panel points that could
be exchanged for gift coupons. The points that each
participant received for completing the questionnaire
about HPV vaccination were worth 4.35 euros. The
response rate of people contacted by this recruitment
strategy was 79% (N = 511) among the mothers, and 69%
(N = 243) among the daughters.
Received invitation
Addresses (n = 5,998)
Received invitation 
Mothers (n = 650)
Daughters (n = 350)
Completed survey
Mothers (n = 445)
Daughters (n = 404)
Completed survey
Mothers (n = 511)
Daughters (n = 243)
Excluded (n = 2; 
unknown address)
Received reminder
Addresses (n = 5,929)
Started with survey
Mothers (n = 564)
Daughters (n = 537)
Praeventis random sample
Dutch addresses (n = 6,000) of girls born in 1995 or 
1996 stratified by ethnicity and vaccine uptake.
Ethnicity:
- 3,300 general sample;
- 2,700 selected sample of which 900 per ethnical 
group (Turkey, Morocco, and Surinam/Antilles).
Vaccine uptake per general/selected sample:
- One third with girls with    1 HPV injection;
- Two thirds with girls with 0 injections.
Online panel random sample
Mothers of girls born in 1995 or 1996 (n = 650) 
Daughters (n = 350 of the sample of mothers)
Data available for analyses
Mothers (n = 952)
Daughters (n = 642)
Excluded
Mothers (n = 4): male (n = 3), invalid age (n = 1)
Daughters (n = 5): male (n = 2), invalid age (n = 3)
Figure 1 Flow diagram of the recruitment and response of study participants.
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daughters (10%) were available for the intended analyses.
The total sample included 497 mother-daughter pairs,
and 455 and 145 independent mothers and daughters,
respectively.Questionnaire
The online questionnaire was based on information derived
from former empirical research on general vaccination
intention, HPV vaccination intention (see Table 1 for refer-
ences) and qualitative focus groups with representatives
Table 1 Overview of social-psychological scale measures1










־ HPV is sexually transmittable; −1 = incorrect −8 = incorrect 8 n/a
־ HPV is a virus; 0 = don’t know 8 = correct
־ The HPV vaccination in the Netherlands
consists of three injections;
1 = correct
־ My daughter is/I am obliged to get the
HPV vaccination when she is/I am invited;
־ You will always notice when you are
infected by HPV;
־ Only women can get infected by HPV;
־ Women who received the HPV vaccination
are still advised to participate in the cervical
cancer screening in the Netherlands;





Imagine that your daughter was/you were not
vaccinated against HPV. The chance that my
daughter will get/I will get cervical cancer is. . .
−3 = very small
to 3 = very large




Imagine that your daughter was/you were
vaccinated against HPV. The chance that my
daughter will get/I will get cervical cancer is. . .
−3 = very small
to 3 = very large
n/a 1 n/a [20,31]
Attitude towards
the HPV vaccination
Vaccinating my daughter/myself against
HPV is. . .
−3 = very undesirable
to 3 = very desirable;
−12 = negative
to 12 = positive
4 M = .98 [31]
D = .94
−3 = very bad
to 3 = very good;
−3 = very negative
to 3 = very positive;
−3 = very
unimportant to




If my daughter gets/I get the HPV
vaccination. . .
−3 = completely






5 M = .60 [20,27,32]
D = .49
־ she/I will become infertile;
־ she/I will get unpleasant side effects shortly
after the injection, such as head ache, fever
or pain at the injection spot;
־ she/I will be afraid of the injection with
a needle;
־ she/I will have unsafe sex in the future;
־ her/my natural immune system against




If my daughter gets/I get the HPV
vaccination. . .
−3 = completely
disagree to 3 =
completely agree
−9 = completely
disagree to 9 =
completely agree
3 M = .76 [33,34]
D = .77
־ she/I will not contract cervical cancer;
־ she/I will not have to worry about
cervical cancer;




Imagine your daughter has not received the
HPV vaccination and she gets cervical cancer
in the future. How much would you regret
your decision to let her receive no vaccination?
1 = no regret and






Imagine your daughter has received the HPV
vaccination and she gets a serious illness as
a result of the vaccine. How much would
1 = no regret and
5 = very much
regret
n/a 1 n/a
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Table 1 Overview of social-psychological scale measures1 (Continued)




־ If the government offers the vaccination,
I assume it will be safe;
−3 = completely
disagree to 3 =
completely agree
−18 = negative
to 18 = positive
9 M = .80 [19,20]
D = .70
־ Our government shows responsibility for
the health of the Dutch population by
introducing the HPV vaccination;
−3 = completely
agree to 3 =
completely disagree
־ The HPV vaccination was only introduced
because the pharmaceutical industry will
earn a lot of money from it;
־ There is too little known about whether
the HPV vaccination effectively protects
against cervical cancer;
־ There is too little known about the
detrimental side effects of the HPV
vaccination;
־ My daughter is/I am too young to
receive the HPV vaccination;
־ My daughter does/I do not need to
get the HPV vaccination if she is/I am
already sexually active;
־ My daughter does/I do not need the
vaccination because she is/I am not
yet sexually active;
־ It is inappropriate that my daughter
has/I have to pay for the HPV vaccination
if she decides/I decide to get the




How would you rate the effectiveness of
the following methods of preventing
cervical cancer:
1 = not at all
effective to 10 =
very effective
n/a 5 n/a
־ having safe sex
־ having sex with only one person in
a lifetime
־ participating in the cervical cancer screening
־ having a healthy lifestyle (e.g. not smoking)
־ the HPV vaccination





During my decision making about
my daughter’s/my HPV vaccination. . .
−3 = completely
disagree to 3 =
completely agree
−9 = completely
disagree to 9 =
completely agree
3 M = .93
D = .85
־ I felt torn between the pros and cons
of vaccination;
־ I experienced positive as well as
negative feelings;






As regards the HPV vaccination, how
much confidence do you have in. . .
−3 = very little
to 3 = very much
confidence
−9 = very little
to 9 = very much
confidence




־ the Ministry of Public Health
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Table 1 Overview of social-psychological scale measures1 (Continued)










70 = positive (M);
M = 7 M = .85 [31]
What is your expectation on the opinion
of . . . about the HPV vaccination of
your daughter?
D = 6 D = .77
3 = not applicable; −60 =negative to
60 = positive (D)
Not applicable was
recoded into ‘0’
Social referents: partner (M), parents (M),
daughter (M), father (D), mother (D), best
friends (M/D), general practitioner (M/D),
doctor/nurse from the municipal health
service (M/D), the Ministry of Public
Health (M/D)
Motivation to comply 1 = not at all to
5 = very much
M = 7 [31]
How motivated are you to comply with





How many parents/girls do you know who
will decide to let their daughter/themselves
be vaccinated against HPV if they receive
the invitation?
1 = none of the
parents/girls I know,
to 7 = all the
parents/girls I know




To what extent would you succeed in
dealing with the following situations:
−3 = I would
certainly not
succeed to 3 = I
would certainly
succeed
−18 = I would
certainly not
succeed to 18 = I
would certainly
succeed
6 M = .82
D = .66
־ Finding reliable information about the
HPV vaccination;
־ Understanding information about the
HPV vaccination;
־ Making a different decision about the
HPV vaccination of my daughter/myself than
most parents/girls among my acquaintances;
־ Having a good talk with my daughter
about the HPV vaccination (M);
־ Having a good talk with my partner
about the HPV vaccination (M);
־ Having a good talk with my father
about the HPV vaccination (D);
־ Having a good talk with my mother
about the HPV vaccination (D);
־ Having a good talk with my general
practitioner about the HPV vaccination.
HPV vaccination
information processing
Before I finally decided about my (daughter’s)
vaccination, I. . .
−6 = completely
disagree to 6 =
completely agree
2 M = .84 [31]
D = .75
־ gathered a lot of information about the
HPV vaccine
־ thoroughly considered the HPV vaccination −3 = completely
disagree to 3 =




Letting my daughter receive the HPV
vaccination/Receiving the HPV vaccination
is something I do. . .
−3 = completely
disagree to 3 =
completely agree
−6 = completely
disagree to 6 =
completely agree




Participants rated their agreement on
both items separately
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As regards the HPV vaccination. . . −3 = completely
disagree to 3 =
completely agree
−9 = completely
disagree to 9 =
completely agree
3 M = .89 [36]
־ I was clear about which benefits were
most important to me;
D = .85
־ I was clear about which risks were
most important to me;
־ I was clear about which was more




As regards the HPV vaccination. . . −3 = completely
disagree to 3 =
completely agree
−9 = completely
disagree to 9 =
completely agree
3 M = .89 [36]
D = .87־ I felt sure about what to choose;
־ the decision was relatively easy to make;




In what way do you agree with the view of. . . −3 = completely
disagree to 3 =
completely agree
−9 = completely
disagree to 9 =
completely agree
3 M = .81
־ anthroposophy D = .76
־ homeopathy
־ other alternative medicine
Past cancer
experienced
Have you/has your mother had experience
with. . .
1 = no, 2 = yes,
3 = I do not want to
answer this question
n/a 6 n/a [19,27]
Do you know someone from your
close environment who has/has had. . .
־ cervical cancer
־ other cancers
־ abnormal pap smear
Notes M = Mother; D = Daughter; n/a = not applicable; 1Scores on scaled item that showed sufficient internal consistency were summed into one scale; Mothers
received questions about the HPV vaccination of their daughter, whereas daughters answered questions about the HPV vaccination of themselves; a) Knowledge
is not a scale because the answer on one item does not predict the answer on the other items; the items were summed up to present a sum score of knowledge;
b) The difference between the rated effectiveness of the HPV vaccination and the most effective alternative represented the relative effectiveness score
(−9 = HPV vaccination least effective to 9 = HPV vaccination most effective); c) The subjective norms score was first computed by multiplying normative
beliefs and motivation to comply for each social referent, and then by summing up the multiplications of the social referents; d) Past cancer experience is
not a scale because the answer on one item does not predict the answer on the other items.
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[28], Social Cognitive Theory [29] and the Health Belief
Model [30] formed the theoretical framework of this study.
Mothers received questions about the HPV vaccination
of their daughter, whereas daughters answered questions
about the HPV vaccination of themselves. The question-
naire was pretested on a small sample from the study popu-
lation, and subsequently revised. The revised questionnaire
is described below.
Vaccination intention
Because social-psychological factors were measured at
present and vaccination intention refers to future behavior,
vaccination intention rather than past vaccination behavior
was used as the criterion variable for examining the
relationship between social-psychological factors and the
HPV vaccination decision. Intention is a powerful predictor
of infrequently performed behavior, such as obtaining a
vaccination [37]. Vaccination intention was assessed by
asking “If you had to make the HPV vaccination decision
again, would you vaccinate your daughter/yourself against
HPV?” (−3 = certainly not, to 3 = certainly yes) [31].Vaccination uptake
Vaccination uptake was assessed by a dichotomous variable
representing complete vaccination (no = received less than
three HPV injections; yes = received all three HPV
injections). For participants recruited via Praeventis, HPV
vaccination uptake information was available via the
Praeventis vaccine register (i.e., number of HPV injections)
as well as the survey (i.e., “Has your daughter received/Did
you receive all three HPV injections?” (yes/no)). The
percentage of agreement between objective and self-
reported vaccination uptake for mothers and daughters
from the Praeventis sample was determined by comparing
the association between the Praeventis registry information
with responses in the questionnaire. For participants
recruited by the online panel, HPV vaccination uptake was
available only via the survey (“How many HPV injections
did your daughter/you receive?” (0 to 3 injections)).
Social-psychological factors
Social-psychological factors included knowledge, risk
perception, attitude, outcome expectations, anticipated
regret, beliefs, perceived relative effectiveness of the
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authorities, subjective norms, descriptive norms, self-
efficacy expectations, information processing, habit,
decisional conflict (certainty, and value clarity), opinions
about alternative medicine and past cancer experience
(see Table 1 for an overview of the measures, sample
items and the Cronbach’s alpha). Scores on items that,
taken as a group, had meaningful content coverage [38]
and showed sufficient internal consistency (Cronbach’s
alpha > 0.60 in at least one of the two samples) were
summed into one scale. With regard to risk perception
(i.e., perceived susceptibility and perceived severity),
perceived severity was not measured because low variability
was expected and a recent review showed no association
with vaccine intention [12].
Socio-demographic factors
Socio-demographic factors were included to explore the
need for segmentation of target groups in future
educational interventions. The study accounted for age,
gender, educational level, country of birth and religion.
Level of education was measured by asking mothers
about the highest level of education that they had
completed and by asking daughters about their own
education and the highest level of education both their
parents had completed (the parent with the highest
completed educational level was used to rank the
educational level of the parents). Highest completed
educational level for adults was classified as low (less
than secondary or vocational education), intermediate
(secondary through pre-university education) or high
(professional or university education). For the daughters,
attained educational level was classified as intermediate
(senior general secondary education or pre-university
education) or low (other).
Country of birth was also assessed for mothers and
daughters. The variables were classified into four cat-
egories which represent the largest ethnic groups in the
Netherlands and matched our recruitment strategy:
Netherlands, Surinam/Antilles/Aruba, Turkey/Morocco
and other countries.
Religion was measured by asking participants about
their religious convictions (Protestant, Roman Catholic,
Muslim, Jewish, Buddhist, Hindu, other or no religion).
Because a small minority of participants had another
religion than Roman Catholic or Protestant, these partici-
pants were classified as “Roman Catholic” and people with
“no religion” were put in the category “no religion”. This
information was further dichotomized into “Protestant” or
“not Protestant” because an ANOVA revealed that Protest-
ant participants had a significantly lower vaccine intention
than Roman Catholics or people with no religion. Finally,
we asked participants if the parents had differences in
opinion about the acceptability of the HPV vaccine.Data analyses
In all analyses, education level was treated as nominal,
instead of ordinal, because we did not assume a mono-
tonic increasing relationship of education level with the
outcome variable “HPV-vaccination intention”. The
association between objective and self-reported vaccination
uptake (i.e., received all three HPV injections versus
received less than three HPV injections) for mothers and
daughters was determined by chi-square tests. Differences
between participants recruited from Praeventis and the
online panel were examined by t-tests or chi-square
tests with Statistical Package for Social Sciences (SPSS)
17.0. A two-sided alpha of .05 was used as the criterion
for significance.
HPV vaccination intention was used as the criterion
variable for examining the relationship between social-
psychological factors and the HPV vaccination decision,
as it is consistent with behavioral theories (e.g., Theory
of Planned Behavior) that explain future behavior via
intention, by social-psychological determinants measured
at present. We first examined the univariate relationship
between social-psychological factors and vaccination
intention with simple regression analysis. Because of the
large amount of univariate tests, we used a two-sided
alpha of .01 as the criterion for significance. Secondly, we
conducted a backward linear regression analysis to examine
which social-psychological factors were most dominantly
associated with vaccination intention. Only significant
factors from the univariate tests were included in the
regression analyses as predictors in a fourth step, after
correcting for HPV vaccination uptake in the first step,
sample in the second step and socio-demographic
variables in a third step. HPV vaccination uptake was
included in the regression analysis as a first step
because past behavior best predicts future behavior
[28]. A two-sided p ≥ .01 was used as the criterion for re-
moval of a predictor in the backwards selection procedure.
HPV vaccination uptake, sample, socio-demographic and
social-psychological factors were included in the model by
the forced entry method to determine their unique
explained variance on vaccination intention.
To select the most important factors, the backward
method was used to exclude non-significant variables
(two-sided p ≥ .01) from the model, except for HPV
vaccination uptake, sample and socio-demographic
variables for which differences were found between the
two samples. Because we wanted to adjust for the latter
variables in the final model, we applied a manually back-
ward selection, instead of an automatic procedure. There
was no indication of multicollinearity between variables in
the regression model (variance inflation factor values < 10).
To further shape future recommendations, Pearson’s
correlation coefficients were calculated for the relationship
between vaccination intention and individual study
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intention according to the multiple regression model.
The univariate and multivariate tests were first performed
on a random sample of 75% of the participants. Data from
the other (25%) participants were used to check for stability
and generalizability. The stability check examined which
predictors from the final regression model among the 75%
sample remained significant in the 25% sample; these were
expected to be stable predictors. The generalizability check
examined the predictive value of the final regression models
for the vaccination intention of the population. This check
was conducted to account for overestimation of the
percentage of explained variance which mostly occurs in a
regression analysis. The goodness-of-fit of the final
regression model for the 75% sample was estimated
for the 25% sample by keeping the estimated parameters
(Betas) of the regression model for the 75% sample. This
analysis was performed in R [39]. Subsequently, the
percentage of explained variance was compared between
the two samples, with large differences indicating a large




In total, we analyzed data from 952 mothers and 642
daughters. No data were available from participants who
did not respond to the invitation. The sample description
is depicted in Table 2.
Socio-demographic factors
The mean age of the mothers and daughters was 43
years (SD = 4.6) and 13 years (SD = 0.5), respectively.
Most of the mothers (88%) and daughters (75%) were
born in the Netherlands, and 24% and 18% were Protestant,
respectively. One quarter of the mothers (26%) had a low
educational level. More than half of the girls (58%) attained
a low educational level. The sample appeared to represent
the general population in the Netherlands with regard to
educational level [41], country of birth [42] and religion
[43]. A small percentage (5%) of mothers who had a partner
(n = 880) indicated that they differed in opinion from
their partner about the HPV vaccination. Eight percent
of the daughters who had two parents (n = 595) indi-
cated that their parents differed in opinion about the
HPV vaccination.
Vaccination intention
Less than half of the mothers (45%) and daughters (39%)
indicated that they would like or certainly like to receive
the HPV vaccination if they were to decide in the future
(Table 2). Among the mother-daughter pairs (n = 497),
the vaccination intention of mothers strongly correlated
with that of daughters (r = .77; p < .001).Vaccination uptake
Almost half of the mothers (45%) indicated that their
daughter received all three HPV injections in 2009, and
51% of the daughters indicated that they had received
them. The association between objective and self-
reported data on the number of received HPV injections
(“has not received all three injections” versus “has
received all three injections”) in the Praeventis sample
was high (mothers: n = 441; χ2 = 290.56; p < .001;
daughters: n = 399; χ2 = 325.02; p < .001), and the
percentage of agreement between both outcome
variables appeared very large (91% for mothers and 94%
for daughters). The correlation between HPV vaccin-
ation uptake and future vaccination intention was also
significant for mothers (r = .69; p < .001) and daughters
(r = .62; p < .001).
Differences between participants recruited via Praeventis
and the online panel
Compared to mothers recruited via the online panel,
those recruited via Praeventis were older (online panel
43.0 versus Praeventis 43.8 years of age; t = 2.69, p = .007,
Table 2) and had completed a higher level of education
(24% versus 37%; χ2 = 17.73, p < .001), fewer mothers were
born in the Netherlands (97% versus 77%; χ2 = 94.23,
p < .001) and fewer mothers were Protestant (29% versus
18%; χ2 = 13.43, p < .001). Among mothers, there were no
differences between the samples with regard to HPV
vaccination intention (p = .95) and vaccination uptake
(p = .68).
Compared to daughters recruited via the online panel,
those recruited via Praeventis were more likely to have
parents with a lower completed level of education (17%
versus 26%; χ2 = 17.14, p < .001), were less likely to
attain a lower educational level themselves (84% versus
43%; χ2 = 103.93, p < .001), were less likely to have a
mother who was born in the Netherlands (96% versus
63%; χ2 = 90.66, p < .001), were less likely to have been
born in the Netherlands themselves (98% versus 90%;
χ2 = 17.97, p < .001) and were less likely to be Protestant
(22% versus 15%; χ2 = 4.94, p = .03). Among daughters,
there were no differences between the samples with regard
to age (p = .73), HPV vaccination intention (p = .28) and
vaccination uptake (p = .36).
Relationship between determinants and the HPV
vaccination intention
Univariate tests
According to the univariate regression analyses, the
following factors significantly contributed to the mothers’
(Table 3) and daughters’ (Table 4) HPV vaccination
intention: HPV vaccination uptake, religion, risk perception
without having received the HPV vaccination, attitude,
positive and negative outcome expectations, anticipated
Table 2 Sample description (percentage or mean ± standard deviation)1
Variables Mothers Daughters
Praeventis (n=441) Panel (n=511) Total (n=952) Praeventis (n=399) Panel (n=243) Total (n=642)
Age 43.81 ± 4.74 43.01 ± 4.48 43.38 ± 4.62* 13.52 ± 0.51 13.50 ± 0.51 13.51 ± 0.51
Educational level mother Nmissing = 2 Nmissing = 2* - - -
Low 24% 27% 26%
Intermediate 39% 49% 44%
High 37% 24% 30%
Educational level parents - - - Nmissing = 19 Nmissing = 19 Nmissing = 38*
Low 26% 17% 22%
Intermediate 34% 26% 31%
High 40% 57% 46%
Educational level daughter - - - n=238 n=637*
Low 43% 84% 58%
Intermediate 57% 16% 42%
Country of birth mother Nmissing = 1 Nmissing = 3 Nmissing = 4* Nmissing = 10 Nmissing = 20 Nmissing = 30*
The Netherlands 77% 97% 88% 63% 96% 75%
Surinam/Antilles 8% 1% 4% 11% 1% 7%
Turkey/Morocco 10% 0% 5% 21% 0% 13%
Other 5% 2% 3% 5% 3% 4%
Country of birth daughter - - - *
The Netherlands 90% 98% 93%
Surinam/Antilles 3% 0% 2%
Turkey/Morocco 4% 0% 2%
Other 3% 2% 3%
Religion Nmissing = 2 Nmissing = 1 Nmissing = 3* *
Protestant 18% 29% 24% 15% 22% 18%
Number of HPV injections2 1.42 ± 1.45 1.59 ± 1.42 1.51 ± 1.44 1.47 ± 1.46 1.72 ± 1.44 1.56 ± 1.46
None 50% 43% 46% 49% 40% 46%
One 1% 1% 1% 1% 1% 1%
Two 6% 10% 8% 5% 6% 5%
Three 43% 46% 45% 45% 53% 48%
Three HPV injections received
(self-reported)
45% 46% 45% 49% 53% 51%
HPV vaccination intention 0.57 ± 2.07 0.57 ± 2.20 0.57 ± 2.14 0.43 ± 1.98 0.61 ± 2.03 0.50 ± 2.00
Certainly not 12% 14% 13% 11% 10% 11%
Not 8% 12% 10% 9% 10% 9%
Probably not 12% 9% 11% 13% 11% 12%
Probably not/yes 11% 7% 9% 15% 14% 15%
Probably yes 14% 10% 12% 16% 12% 14%
Yes 19% 22% 20% 17% 18% 17%
Certainly yes 24% 26% 25% 20% 25% 22%
Notes 1) In case of missing values, the number of missing values (Nmissing) were presented; Mothers received questions about the HPV vaccination of their
daughter, whereas daughters answered questions about the HPV vaccination of themselves; 2) These number represents daughters and are obtained from the
vaccine registration for participants recruited via Praeventis, and are self-reported for participants recruited via an online panel; *Significant difference between
Praeventis and the panel (p < .05).
van Keulen et al. BMC Public Health 2013, 13:111 Page 11 of 21
http://www.biomedcentral.com/1471-2458/13/111
van Keulen et al. BMC Public Health 2013, 13:111 Page 12 of 21
http://www.biomedcentral.com/1471-2458/13/111regret with and without having received the HPV
vaccination, beliefs, relative effectiveness of the HPV
vaccination, confidence in responsible authorities, subject-
ive norms, descriptive norms, information processing and
habit strength. Among mothers, significance was also found
for ambivalence, decisional conflict (certainty) and opinion
about alternative medicine; among daughters, significance
was also found for self-efficacy and decisional conflict
(values clarity).
Multivariate tests
Tables 3 (mothers) and 4 (daughters) present factors that
significantly contributed to the HPV vaccination intention
according to the multivariate regression analyses.
Mothers
The unique contribution of HPV vaccination uptake
(first step) to the explained variance of vaccination
intention was large and significant (R2 = .47, p < .001). In
addition, the samples (second step) did not significantly
contribute to the explained variance of vaccination
intention (ΔR2 = .00; p = .83). The additional contribution
of socio-demographic variables (third step) to the explained
variance of vaccination intention was small but significant
(ΔR2 = .01, p = .007) for country of birth. The multivariate
relationship between country of birth and intention was
not found by the univariate test, which was most likely
caused by the small percentage of mothers born in Turkey
or Morocco (4%). The social-psychological determinants
(fourth step) largely and significantly contributed to the
explained variance of vaccination intention (ΔR2 = .35;
p < .001) after correcting for HPV vaccination uptake,
sample and socio-demographic variables: attitude, antici-
pated regret when accepting or refraining from vaccination,
beliefs, subjective norms, habit strength and decisional con-
flict (certainty). The relationship between decisional conflict
and intention has to be interpreted with caution, because
univariate analyses showed the opposite relationship, which
indicates a possible suppressor-effect. This suppressor-
effect was probably caused by the high correlation between
decisional conflict and habit (r = .49; p < .001).
Daughters
The unique contribution of HPV vaccination uptake
(first step) to the explained variance of vaccination
intention was large and significant (R2 = .36, p < .001).
The additional contribution of sample (second step)
and socio-demographic variables (third step) to the
explained variance of vaccination intention was not
significant (ΔR2 = .00, p = .69; and ΔR2 = .02, p = .17,
respectively), whereas the additional contribution of
social-psychological variables (fourth step) was large
and significant (ΔR2 = .34; p < .001). Attitude, beliefs,
subjective norms and habit strength and risk perception(perceived susceptibility of getting cervical cancer without
having received the HPV vaccination) significantly
and uniquely contributed to the explanation of HPV
vaccination intentions.
Stability
The stability of these models was tested on 25% of the total
sample of mothers (n = 220) and daughters (n = 160).
Results have to be interpreted with caution for country of
birth because of the small percentage of participants born
outside the Netherlands (13% of mothers and 5% of
daughters). The outcomes of these stability tests are also
presented in Tables 3 (mothers) and 4 (daughters).
Mothers
Country of birth and anticipated regret no longer signifi-
cantly contributed to the prediction of HPV vaccination
intention. Attitude, beliefs, subjective norms, habit strength
and decisional conflict (certainty) appeared to be stable
factors since they contributed to the explained variance in
both the 25% and 75% samples.
Daughters
Beliefs, habit strength and risk perception no longer
significantly contributed to the explained variance of
HPV vaccination intention. Anticipated regret when
refraining from vaccination significantly and positively
contributed to HPV vaccination intention for the 25%
sample, though it did not for the 75% sample. Attitude and
subjective norms appeared stable since they significantly
entered the equation in both samples.
Generalizability
The generalizability of determinants of HPV vaccination
intention was explored by replicating the final regression
model found for the 75% samples in the remaining 25%
samples. The explained variance of the final models
remained high for the 25% samples (R2 = .80 for
mothers, R2 = .72 for daughters). This means that the
final models found for the 75% samples appeared to
predict to a large extent the vaccination intention of the
mothers and daughters from the total population.
Influential elements of the HPV vaccination intention
determinants
More detailed insight into the most relevant determinants
might be helpful for defining concrete objectives for
designing interventions to promote HPV vaccination
uptake. These analyses focused on the relative influence of
individual items of the most relevant determinants from
the final regression models (i.e., beliefs, subjective norms
and habit for both mothers and daughters, and decisional
conflict for mothers). Analyses for attitude were not
conducted since the items on this scale were considered
Table 3 Relationship of socio-demographic variables and social-psychological factors with the mothers’ HPV
vaccination intention
Variables Univariate simple regression
analysis among 75% of the
mothers (n = 732)
Multivariate backward
regression analysis among
75% of the mothers (n = 727)
Multivariate backward
regression analysis among












HPV vaccination uptake .48** 0.48 (0.10) .11** 0.57 (0.19) .13*
Has not received three HPV-injections (reference) 54%
Has received three HPV-injections 46%




Age 43.51 (4.54) .00 −0.01 (0.01) -.02 0.00 (0.01) .01
Highest completed level of education mother .00
Low (reference) 25%
Intermediate 45% 0.08 (0.08) .02 −0.02 (0.17) -.00
High 30% 0.13 (0.09) .03 0.27 (0.18) .06
Country of birth mother .00
The Netherlands (reference) 88%
Surinam/Antilles 4% −0.22 (0.18) -.02 0.42 (0.32) .04
Turkey/Morocco 4% −0.51 (0.18) -.05* 0.18 (0.32) .02
Other 3% −0.30 (0.18) -.03 0.10 (0.41) .01
Protestant religion .02**
No (reference) 77%
Yes 23% −0.08 (0.08) -.02 −0.05 (0.15) -.01
Social psychological variables
Knowledge about the HPV vaccination 4.82 (2.42) .00
Risk perception (having received no HPV
vaccination)
−0.61 (1.21) .20**
Risk perception (having received the HPV
vaccination)
−1.22 (1.09) .01
Attitude towards the HPV vaccination 2.78 (6.93) .76** 0.12 (0.01) .39** 0.13 (0.02) .42**
Negative outcome expectations of the HPV
vaccination
7.24 (4.56) .14**
Positive outcome expectations of the HPV
vaccination
−3.44 (3.86) .10**
Anticipated regret about rejecting the HPV
vaccination
3.27 (1.44) .46** 0.20 (0.03) .13**
Anticipated regret about receiving the vaccination 3.38 (1.39) .06** −0.08 (0.03) -.05*
Beliefs about the HPV vaccination 1.42 (9.92) .60** 0.03 (0.01) .14** 0.03 (0.01) .12*
Relative effectiveness of the HPV vaccination −0.61 (1.20) .54**
Ambivalence towards the HPV vaccination
decision
0.36 (5.30) .01*
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Table 3 Relationship of socio-demographic variables and social-psychological factors with the mothers’ HPV
vaccination intention (Continued)
Confidence in authorities involved in the
HPV vaccination
1.60 (3.49) .42**
Subjective norms towards the HPV vaccination 16.81 (23.57) .67** 0.02 (0.00) .19** 0.02 (0.01) .20**
Descriptive norms towards the HPV vaccination 4.53 (1.34) .15**
Self-efficacy expectations towards the
HPV vaccination
11.87 (4.66) .01
HPV vaccination information processing 3.79 (2.40) .06**
Habit strength towards the HPV vaccination −0.81 (3.64) .41** 0.07 (0.02) .11** 0.12 (0.03) .19**
Decisional conflict about the HPV
vaccination – value clarity
3.03 (4.29) .00
Decisional conflict about the HPV
vaccination – certainty
2.00 (4.69) .02** −0.05 (.01) -.10** −0.07 (0.02) -.15**
Opinion about alternative medicine −0.43 (2.37) .02*
Past experience of the mother with cervical cancer .00
No (reference) 98%
Yes 2%










Past experience of someone from the




Past experience of someone from the




Past experience of someone from the close




Model fit for multivariate models
R2 of HPV vaccination uptake .47 .48
R2 change of HPV vaccination uptake .47 .48
F change of HPV vaccination uptake 653.97** 198.23**
R2 of HPV vaccination uptake + sample .47 .48
R2 change of HPV vaccination uptake + sample .00 .00
F change of HPV vaccination uptake + sample 0.04 0.36
R2 of HPV vaccination uptake + sample +
socio-demographic variables
.49 .50
R2 change of HPV vaccination uptake +
sample + socio-demographic variables
.01 .02
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Table 3 Relationship of socio-demographic variables and social-psychological factors with the mothers’ HPV
vaccination intention (Continued)
F change of HPV vaccination uptake +
sample + socio-demographic variables
2.82* 1.37
R2 of HPV vaccination uptake + sample + socio-
demographic + social-psychological variables
.84 .81
R2 change of HPV vaccination uptake + sample +
socio-demographic + social-psychological variables
.35 .31
F change of HPV vaccination uptake + sample +
socio-demographic + social-psychological variables
218.92** 66.04**
Notes 1) R**2; Mothers received questions about the HPV vaccination of their daughter, whereas daughters answered questions about the HPV vaccination of
themselves; *p < .01; **p < .001.
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this respect.
Beliefs
The following beliefs significantly (all p < .001 unless
mentioned) correlated with the HPV vaccination intention
of both mothers and daughters (The scales differ for posi-
tive (−3 = completely disagree to 3 = completely agree) and
negative (−3 = completely agree to 3 = completely disagree)
beliefs (see Table 1 for details). A higher score represents a
more positive opinion about HPV vaccination): “If the
government offers the vaccination, I assume it will be safe”
(rMother (rM) = .65 and rDaughter (rD) = .57); “The HPV
vaccination was only introduced because the pharmaceut-
ical industry will earn a lot of money from it” (rM = .60
and rD = .40); “Our government is showing responsibility
for the health of the Dutch population by introducing the
HPV vaccination” (rM = .60 and Dr = .24); “There is too
little known about whether the HPV vaccination effectively
protects against cervical cancer” (rM = .59 and rD = .53);
“There is too little known about the detrimental side effects
of the HPV vaccination” (rM = .57 and rD = .42);
“My daughter is too young to receive the HPV vaccination”
(rM = .57 and rD = .40); and “My daughter does not need
to get the HPV vaccination if she is already sexually active”
(rM = .19; rD = .48, p = .001). The belief that a daughter
does not need the vaccination because she is not yet
sexually active positively and significantly correlated
with the mothers’ HPV vaccination intentions (r = .63),
whereas this relationship was not significant among
daughters (r = .10; p = .03). The belief that it is
inappropriate that the daughter has to pay for the HPV
vaccination if she decides to get the vaccination at a
higher age was positively and significantly related to
the HPV vaccination intention of daughters (r = .23),
while it was not significantly related to the intention of
mothers (r = .05; p = .21).
Subjective norms
Mothers and daughters were significantly more likely to
vaccinate against HPV when they expected a positiveinfluence from their friends (rM = .58 and rD = .39),
general practitioners (rM = .52 and rD = .42), physicians
or nurses from the municipal health service (rM = .46
and rD = .41) and the Ministry of Health (rM = .42 and
rD = .29; all p < .001). This also applied to mothers when
they expected a positive influence from their partners
(r = .80), daughters (r = .76) and parents (r = .66), and
to daughters when they expected a positive influence from
their mothers (r = .71) and fathers (r = .62; all p < .001).
Habit strength
Mothers and daughters were more inclined to accept the
HPV vaccination when they perceived it as an automatic
event (rM = .70 and rD = .61), without much thinking
(rM = .47 and rD = .35; all p < .001).
Decisional conflict (certainty)
Decisional conflict (certainty) significantly contributed
to the mothers’ HPV vaccination intention. Mothers
were more likely to let their daughter receive the HPV
vaccination if they perceived the decision as relatively
easy to make (r = .22; p < .001). The item “As regards
the HPV vaccination, I was clear about the best choice for
my daughter” was borderline significant (r = .09; p = .01);
mothers seemed more likely to let their daughter receive
the HPV vaccination if they agreed with this statement.
The other item on this scale was not significantly asso-
ciated with the mothers’ HPV vaccination intentions:
“As regards the HPV vaccination, I felt sure about what
to choose” (r = .04; p = .28).
Discussion
This paper presents empirically tested the social-
psychological determinants of the HPV vaccination
intention among girls and their mothers who received
an invitation for the first Dutch catch-up campaign in
2009. This is one of the first studies to examine these
determinants among participants who had actually
made the decision about the HPV vaccination in the
preceding year. Our results into determinants of the
HPV vaccination decision confirm results from previous
Table 4 Relationship of socio-demographic variables and social-psychological factors with the daughters’ HPV
vaccination intention
Variables Univariate simple regression
analysis among 75% of the
daughters (n = 482)
Multivariate backward
regression analysis among
75% of the daughters (n = 452)
Multivariate backward
regression analysis among












HPV vaccination uptake .35** 0.36 (0.14) .09* 0.92 (0.25) .23**
Has not received three HPV-injections
(reference)
52
Has received three HPV-injections 48




Age 13.51 (0.51) .00
Educational level daughter .00
Low (reference) 59%
Intermediate 41% 0.22 (0.12) .06 −0.11 (0.21) -.03




Intermediate 32% 0.08 (0.15) .02 0.18 (0.24) .04
High 46% 0.04 (0.15) .01 0.31 (0.23) .08
Country of birth mother .00
The Netherlands (reference) 74%
Surinam/Antilles 7% 0.05 (0.24) .01 0.08 (0.41) .01
Turkey/Morocco 15% −0.09 (0.19) -.02 0.25 (0.34) .04
Other 4% 0.08 (0.26) .01 −1.18 (0.45) -.13
Country of birth daughter .00
The Netherlands (reference) 92%
Surinam/Antilles 2% −0.74 (0.43) -.05 −0.03 (0.59) −0.00
Turkey/Morocco 3% 0.21 (0.33) .02 - -
Other 3% 0.35 (0.33) .03 1.62 (0.56) .13*
Protestant religion .02*
No (reference) 82%
Yes 19% 0.02 (0.13) .00 −0.15 (0.23) -.03
Social psychological variables
Knowledge about the HPV vaccination 3.59 (2.41) .00
Risk perception (having received no
HPV vaccination)
−0.61 (1.39) .23** 0.19 (0.04) .13**
Risk perception (having received the
HPV vaccination)
−1.49 (1.22) .00
Attitude towards the HPV vaccination 2.43 (6.02) .62** 0.12 (0.01) .37** 0.14 (0.03) .39**
Negative outcome expectations of the
HPV vaccination
5.66 (4.71) .09**
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Table 4 Relationship of socio-demographic variables and social-psychological factors with the daughters’ HPV
vaccination intention (Continued)
Positive outcome expectations of the HPV
vaccination
−1.02 (4.17) .10**
Anticipated regret about rejecting the HPV
vaccination
3.24 (1.43) .27** 0.24 (0.08) .17*
Anticipated regret about receiving the
vaccination
3.11 (1.52) .09**
Beliefs about the HPV vaccination 2.11 (8.31) .47** 0.05 (0.01) .21**
Relative effectiveness of the HPV vaccination −2.45 (2.61) .36**
Ambivalence towards the HPV vaccination
decision
−0.11 (4.64) .00
Confidence in authorities involved in the
HPV vaccination
1.46 (3.49) .29**
Subjective norms towards the HPV vaccination 13.87 (18.60) .46** 0.02 (0.00) .15** 0.03 (0.01) .23*
Descriptive norms towards the HPV
vaccination
4.51 (1.42) .11**
Self-efficacy expectations towards the
HPV vaccination
1.43 (4.70) .06**
HPV vaccination information processing 1.00 (3.16) .03**
Habit strength towards the HPV vaccination −0.28 (3.02) .32** 0.08 (0.02) .12**
Decisional conflict about the HPV
vaccination – value clarity
1.92 (3.99) .02*
Decisional conflict about the HPV
vaccination – certainty
2.06 (4.12) .01
Opinion about alternative medicine −0.28 (1.65) .00















Past experience of someone from the




Past experience of someone from the




Past experience of someone from the close
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Table 4 Relationship of socio-demographic variables and social-psychological factors with the daughters’ HPV
vaccination intention (Continued)
Model fit for multivariate models
R2 of HPV vaccination uptake .36 .49
R2 change of HPV vaccination uptake .36 .49
F change of HPV vaccination uptake 257.28** 137.34**
R2 of HPV vaccination uptake + sample .36 .49
R2 change of HPV vaccination uptake + sample .00 .00
F change of HPV vaccination uptake + sample 0.16 0.58
R2 of HPV vaccination uptake + sample +
socio-demographic variables
.38 .54
R2 change of HPV vaccination uptake +
sample + socio-demographic variables
.02 .05
F change of HPV vaccination uptake +
sample + socio-demographic variables
1.41 1.54




R2 change of HPV vaccination uptake +
sample + socio-demographic +
social-psychological variables
.34 .24
F change of HPV vaccination uptake +
sample + socio-demographic +
social-psychological variables
109.17** 45.91**
Notes 1) R**2; Mothers received questions about the HPV vaccination of their daughter, whereas daughters answered questions about the HPV vaccination of
themselves; *p < .01; **p < .001.
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tion (i.e., when girls and parents did not have to make the
decision in the immediate future). Another insight of this
study is that we combined various predictors from social-
psychological research used in previous studies in one
comprehensive set. As such, we were able to demonstrate
which predictors of the set proved to be a sufficient, stable
and generalizable combination. This is also one of the
first studies that examined the contribution of these
determinants to the explained variance of the HPV
vaccination decision. This study revealed that HPV
vaccination uptake made the largest contribution to
the explained variance of HPV vaccination intention.
We also found that social-psychological factors were
far more important than socio-demographic factors in
explaining the HPV vaccination intention. Moreover,
social-psychological factors appeared to predict to a
considerable extent the HPV vaccination intention of
mothers and daughters from the total population.
HPV vaccination uptake made the largest contribution
to the explained variance of HPV vaccination intention
(47% among mothers, 36% among daughters). It is a
common finding that past behavior is the best predictor
of future behavior [28]. Secondary analyses revealed that
exclusion of HPV vaccination uptake from the regression
model did not decrease the prediction of HPV vaccination
intention (mothers: R2 = .83 excluding and R2 = .84including HPV vaccination intake; daughters: R2 = .73
including and excluding HPV vaccination intake). In
addition, secondary analyses showed that social-
psychological variables explained more than two-thirds
of the variance in HPV vaccination intention when
HPV vaccination uptake was excluded from the model
(mothers: ΔR2 = .80; daughters: ΔR2 = .69). These
results indicate that our final regression model was
sufficient and contained all important social-psychological
determinants [28].
The contribution of social demographic variables to
the explained variance of the HPV vaccination intention
appeared small (≤ 5%) and inconsistent. In contrast, the
contribution of social-psychological determinants to the
explained variance of the HPV vaccination intention was
considerable (35% among mothers, 34% among daughters).
This was an important finding, because the implications
for future HPV vaccination communication are best found
through these ‘modifiable’ social-psychological determi-
nants of the HPV vaccination decision. Social-psychological
factors that were not related to the HPV vaccination
intention were, for example past cancer experiences and
knowledge. With regard to past cancer experience, results
of the present study confirm outcomes from a systematic
review on HPV vaccination intention [12] and a study on
other vaccinations [44]. These results reject the hypothesis
that people are less willing to comply with national
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with the seriousness of the target diseases as former genera-
tions, just because of the successes of these programs. In
fact, almost all (>75%) study participants knew someone
from their close environment who has or has had cancer
(Tables 3 and 4). The absence of a relationship between
knowledge and HPV vaccination intentions also confirms
the results found by others [12,26,44-46]. This may also be
attributed to the fact that knowledge gaps hardly existed;
the percentage of correct answers was high, especially
among mothers (≥ 70%).
Attitude, beliefs and subjective norms were the social-
psychological factors that appeared to be most strongly
and consistently related to HPV vaccination intentions.
Attitude played the most prominent role in the explanation
of the HPV vaccination intention, confirming previous
findings [16,18,19,47]. The most dominant attitude-based
beliefs were beliefs about the safety and effectiveness of the
HPV vaccine, sexual maturation and optimism (misplaced
or not) about future sexual risk taking, economic profit for
the pharmaceutical industry, and trust in the government’s
policies with respect to prevention of infectious diseases.
Many relationships found in this study confirm others’
findings, such as beliefs about the safety and effectiveness
of the HPV vaccine [12,47], sexual maturation and
perceived future risk taking [12,47] and trust in the
government’s prevention policies [19,21].
With regard to subjective norms, the influence of
important others on HPV vaccination intention was
most dominant for close family members (mother,
father, and daughter). These results are similar to other
studies about HPV vaccination [27] or the intention to
take vaccinations in general [44]. Future communication
strategies should therefore primarily be focused on these
close family members. Aside from the expected social
rewards, the mothers’ parents, friends, the general
practitioner, and the physician or nurse from the regional
health service also played a role in the decision making
process. The impact of the subjective norms of physicians
on HPV vaccination decision making was also previously
found [12,19,20]. Because there was a lot of public debate
about the HPV vaccination among physicians before the
onset of the first catch-up campaign [48], future communi-
cation strategies should also target physicians as important
party to make them aware of their influence on HPV vac-
cination decision making by mothers and daughters.
Social-psychological factors that were also, but less
consistently, related to HPV vaccination intention, were
risk perception, anticipated regret, and habit strength.
As for risk perception, daughters were more inclined to
accept the vaccination if they felt a higher perceived
susceptibility to cervical cancer without the HPV
vaccination. This was also found by others [12,16,17,49].
Mothers were also more inclined to accept the HPVvaccination for their daughter when they anticipated
more feelings of regret if their daughters received no
vaccination and developed cervical cancer later in life.
Mothers who anticipated more feelings of regret if their
daughters contracted a serious illness because of the HPV
vaccination had a lower intention to let their daughters
get the HPV vaccination. Secondary analyses indicated
that the respondents anticipated stronger feelings of regret
towards illness without having received the vaccination
than after having received the vaccination. The importance
of anticipated regret confirms what was found by other
studies on HPV vaccination decision making [50] and
on the intention of child vaccinations in general [44].
With regard to habit, mothers had higher intentions to
let their daughters receive the HPV vaccination if they
perceived getting the vaccination as something they did
automatically or without thinking. This is probably
caused by past confidence in the NIP. However, people
who perceive the HPV vaccination as something one
does automatically, without much thinking, may be
more susceptible to counterarguments compared to
deliberate decision makers [44]. They should therefore
be better prepared for possible confrontation with those
counterarguments [44].
Strengths
One important strength of this study is the generalizability
of the study results: the social-psychological factors
appeared to predict to a large extent the vaccination
intention of mothers and daughters from the total popula-
tion. Another strength was that our final regression model
contained all important social-psychological determinants
[28]. Also, the total study sample was representative for
the Dutch population with regard to educational level
[41], country of birth [42] and religion [43]. This was a
notable strength, because part of our sample was recruited
via an online panel and the representativeness of online
panels may be limited [51]. Another strength was that the
HPV vaccination uptake among study participants corre-
sponded to the national HPV vaccination coverage in
2009 [52]. In addition, self-reported vaccination uptake
appeared to be a reliable measure for the objective vaccin-
ation uptake from the national vaccination register; there
was a high percentage of agreement between them (>90%
of mothers and daughters). Our choice to use the mothers
to represent the parents’ HPV vaccination opinion
appeared to be adequate, since almost all participants
(>90% of mothers and daughters) indicated that there was
no difference in opinion between the parents.
Limitations
The present study had some limitations that are worth
mentioning. First, it was based on a cross-sectional design,
which makes it impossible to draw definite conclusions
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response rate among subjects from the Praeventis sample
was very low (7%). A low response rate (25%) was also
found in another study which recruited parents through
Praeventis to examine their attitude towards universal
vaccination against hepatitis B [53]. The low response rate
in the present study could be explained by the use of
online questionnaires, because using such questionnaires
results in lower response rates than using other types of
questionnaires [54,55]. In addition, the use of a written
invitation to recruit participants could have caused the
low response rate, because such an invitation result in
lower response rates than an e-mail invitation in studies
using online questionnaires [54]. Besides, participants
recruited by Praeventis received no reward for their
participation in the study, whereas participants from the
online panel did. Although the reward was small, it can
increase response rates in questionnaire research [56].
Also, the low response rate among participants from
Praeventis compared to participants from the online panel
could be explained by the differences in the nature between
the samples. Participants from an online panel chose to be
part of that panel and are therefore self-selected. This does
not apply to participants from Praeventis. Finally, response
rates are declining recently [57], probably due to over-
surveying. The usefulness of information gained from a
sample with such a low response rate is questionable. How-
ever, we have reason to believe that the results of this sample
are useful, because the total study sample was representative
for the Dutch population (see also “Strengths”).
Implications
Future research
We recommend a longitudinal research approach in order
to confirm the causality of the associations between social-
psychological factors and HPV vaccination behavior.
Future communication strategies
We recommend future communication addressing
social-psychological variables that appear to be related to
HPV vaccination (i.e. attitude, beliefs, subjective norms,
habit, anticipated regret and perceived susceptibility). For
example, future communication could address important
beliefs about the safety of the vaccine, could reduce
unrealistic optimism about the expected monogamy of the
daughter and could emphasize the importance of receiving
the HPV vaccination before daughters become sexually
active. Furthermore, future communication strategies
about the HPV vaccination should be targeted at daughters
and their parents. Both parents appeared to play the most
important role in mothers’ and daughters’ vaccination
decision making. In addition, we recommend maintaining
or improving confidence in authorities involved in the HPV
vaccination, for example, by preventing conflict of interestwith the pharmaceutical industry, or by communicating
about safety as well as risks of the HPV vaccination. Finally,
a tailored communication approach should be considered,
because it has already been successfully applied to a variety
of health-related behaviors, especially in targeting
social-psychological variables also found in the present
study [58,59].
Conclusions
This is one of the first studies to examine determinants of
the HPV vaccination intention among participants who had
actually made the decision about the HPV vaccination in
the preceding year. The study revealed that social-
psychological factors were far more important than
socio-demographic factors in explaining HPV vaccination
intention. Attitude, beliefs, subjective norms and habit
strength were significantly associated with both the
mothers’ and the daughters’ HPV vaccination intentions.
Moreover, the generalizability of the study results was
adequate. Future communication strategies targeting HPV
vaccination uptake should address these determinants.
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